Leerink Partners Cuts Price Target on Alexion Pharma (ALXN) to $216; Reiterates Outperform

Go back to Leerink Partners Cuts Price Target on Alexion Pharma (ALXN) to $216; Reiterates Outperform
Alexion Pharmaceuticals (NASDAQ: ALXN) Delayed: 182.01 --0 (-0%)
Previous Close $182.01    52 Week High $193.45 
Open $33.31    52 Week Low $110.56 
Day High $182.01    P/E 143.31 
Day Low $182.01    EPS $1.27 
Volume 71